Levi & Korsinsky Initiates Class Action Against Zynex, Inc. for Securities Fraud

Class Action Alert: Levi & Korsinsky vs. Zynex, Inc.



On April 22, 2025, Levi & Korsinsky LLP issued a formal notification to shareholders of Zynex, Inc. regarding a significant class action lawsuit. This legal action arises from allegations of securities fraud impacting investors during the period between March 13, 2023, and March 11, 2025.

Understanding the Nature of the Lawsuit


The complaint centers on claims that Zynex, a publicly traded company on NASDAQ under the ticker symbol ZYXI, allegedly misled its investors by prioritizing false representations of its operations and revenues. The lawsuit details several critical points that underline the basis of these allegations:

1. Excessive Product Shipment: Zynex purportedly shipped medical products, including electrodes, far beyond actual needs, artificially inflating its revenue figures.
2. Insurer Scrutiny: This overproduction led to scrutiny from insurers, including the U.S. military health insurance program, Tricare, raising concerns about compliance and ethics in business practices.
3. Potential Consequences: Such practices put Zynex at risk of severe penalties, including removal from insurer networks, which could severely affect its revenue and operational viability.
4. Misleading Statements: The company's prior positive statements regarding business prospects were determined to be materially misleading or lacking a proper basis.

Deadline for Investors


For investors impacted by these events, there is an urgent timeline to consider. Those who suffered losses during the defined period may submit a request to be appointed as lead plaintiffs. The deadline for this action is May 19, 2025. Interested parties can access additional resources through the case submission link provided by Levi & Korsinsky or contact them directly for more information.

No Financial Obligation for Class Participants


One of the most significant aspects of this class action is the absence of financial risk for participants. Investors can potentially claim compensation for their losses with no out-of-pocket expenses. Levi & Korsinsky has emphasized that participation in the class does not require serving as a lead plaintiff, allowing more investors the opportunity to engage in the lawsuit.

Why Choose Levi & Korsinsky?


With over two decades of experience, Levi & Korsinsky has established itself as a formidable player in securities litigation. The firm has successfully secured hundreds of millions of dollars for shareholders through complex legal processes and has been consistently recognized among the top securities litigation firms in the United States. Their dedicated team seeks to protect the rights of investors against fraudulent activities.

Contact Information


Investors can connect with Levi & Korsinsky for additional guidance through the following contact details:

This lawsuit signals a significant moment for investors of Zynex, Inc., urging stakeholders to actively engage with legal counsel to protect their investment interests. The developments surrounding this case will be crucial for both current and future actions regarding the company’s standing in the market.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.